AlphaFlo marketed by Equus

Next-gen regenerative product manufacturer, Equus Innovations, has marketed AlphaFlo, its canine allograft. The company has also partnered with AlphaLogix, LLC in the marketing.

AlphaFlo is made up of an acellular liquid canine amniotic tissue allograft derived from amnion. The amnion, which is thought to have regenerative, anti-microbial, anti-inflammatory, and anti-fibrotic elements.

"The release of AlphaFlo by AlphaLogix is another exciting regenerative solution for veterinary patients,” said Grant D. Senner, MD, DABRM, and chief executive officer of Equus Innovations. “We are privileged to be partners in advancing these innovative allograft products."

Makeup of the allograft is gathered from healthy canines using sterile equipment during the process of birth without any harm to the animals. Equus also manufactures RenoVo equine allograft, which is sold by distributor Equine Amino Solutions, LLC.

Like0

Dislike0

List
Add

Please enter a comment

Name *

Email address *

Comment *

* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.

I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies

Tag

Like0

Dislike0

EVENTS

Edrapublishing

About Us Authors Contact Us Legal Notes Privacy Search

Top

AlphaFlo marketed by Equus

Comments

List

Add

Tag

More news

Advancing the 3Rs: innovation, implementation, ethics and society

Automated Knowledge-Based Radiation Treatment Planning in Canine and Feline Nasal Tumors

Does Lung Function Imaging Modality Have a Dosimetric Impact On Functional Avoidance Treatment Planning: Assessment Using Prospective Clinical Trial Data

One Committed and Caring NC State Veterinary Student, So Many Choices

Dentalis Earns 5 VOHC® Seals, Positioning for Global Expansion in Animal Health

Newsletter

News of interest

Philanthropic Support and Specialized Surgery Saves Dog with Oral Tumor

Feline asthma syndrome: A retrospective study of the clinical presentation in 29 cats

Feline neurological diseases in a veterinary neurology referral hospital population in Japan

Treatment of cats with feline infectious peritonitis

EVENTS